Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan

[Business Wire] – BETHESDA, Md. & TOKYO–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that its subsidiary, Sucampo AG, has received a $15 million milestone payment from Abbott’s (NYSE: … more

View todays social media effects on ABT

View the latest stocks trending across Twitter. Click to view dashboard

See who Abbott is hiring next, click here to view